TETTAMANTI, SARAH
TETTAMANTI, SARAH
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies
2017 Rotiroti, M; Arcangeli, S; Casucci, M; Perriello, V; Bondanza, A; Biondi, A; Tettamanti, S; Biagi, E
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia
2017 Biondi, A; Magnani, C; Tettamanti, S; Gaipa, G; Biagi, E
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
2017 Arcangeli, S; Rotiroti, M; Bardelli, M; Simonelli, L; Magnani, C; Biondi, A; Biagi, E; Tettamanti, S; Varani, L
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies
2018 Piga, I; Capitoli, G; Denti, V; Tettamanti, S; Galimberti, S; Magni, F; Pagni, F
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions
2018 Piga, I; Casano, S; Smith, A; Tettamanti, S; Leni, D; Capitoli, G; Pincelli, A; Scardilli, M; Galimberti, S; Magni, F; Pagni, F
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia
2018 Magnani, C; Mezzanotte, C; Cappuzzello, C; Bardini, M; Tettamanti, S; Fazio, G; Cooper, L; Dastoli, G; Cazzaniga, G; Biondi, A; Biagi, E
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy
2019 L'Imperio, V; Smith, A; Ajello, E; Piga, I; Stella, M; Denti, V; Tettamanti, S; Sinico, R; Pieruzzi, F; Garozzo, M; Vischini, G; Nebuloni, M; Pagni, F; Magni, F
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System
2020 Rotiroti, M; Buracchi, C; Arcangeli, S; Galimberti, S; Valsecchi, M; Perriello, V; Rasko, T; Alberti, G; Magnani, C; Cappuzzello, C; Lundberg, F; Pande, A; Dastoli, G; Introna, M; Serafini, M; Biagi, E; Izsvák, Z; Biondi, A; Tettamanti, S
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities
2020 Magnani, C; Gaipa, G; Lussana, F; Belotti, D; Gritti, G; Napolitano, S; Matera, G; Cabiati, B; Buracchi, C; Borleri, G; Fazio, G; Zaninelli, S; Tettamanti, S; Cesana, S; Colombo, V; Quaroni, M; Cazzaniga, G; Rovelli, A; Biagi, E; Galimberti, S; Calabria, A; Benedicenti, F; Montini, E; Ferrari, S; Introna, M; Balduzzi, A; Valsecchi, M; Dastoli, G; Rambaldi, A; Biondi, A
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
2020 Magnani, C; Tettamanti, S; Alberti, G; Pisani, I; Biondi, A; Serafini, M; Gaipa, G
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML
2021 Biondi, M; Dotti, G; Biondi, A; Tettamanti, S; Pievani, A; Serafini, M
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia
2021 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia
2021 Biondi, M; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use
2022 Gotti, E; Tettamanti, S; Zaninelli, S; Cuofano, C; Cattaneo, I; Rotiroti, M; Cribioli, S; Alzani, R; Rambaldi, A; Introna, M; Golay, J
Catch me if you can: how AML and its niche escape immunotherapy
2022 Tettamanti, S; Pievani, A; Biondi, A; Dotti, G; Serafini, M
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
2022 Biondi, M; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M